In-depth Discussion on Metastatic Prostate Cancer Treatments and Toxicities

Exploring the latest developments in treating metastatic prostate cancer including radium-223, Lutetium-LU-177 targeted therapy, and second-generation anti-androgens, focusing on mechanisms of action, toxicities, and the significance of drug interactions for patients.